A genome-wide base-editing screen uncovers a pivotal role of paxillin δ ubiquitination in influenza virus infection
Year: 2025
Type: article
Abstract: Dissecting host factors critical for viral infection and understanding their mechanisms of action is critical for identifying drug targets. Here, we leverage a genome-wide CRISPR base-editing screen to identify functional lysine residues in host factors required for influenza A virus (IAV) replication. Multiple host genes, including GSTM4, FLNC, HMGB1, ZNF236, GRIP1, and PXN, along with regulatory lysine codons, are identified. Among these, paxillin (encoded by PXN) is identified as an important host entry factor. Depletion of paxillin significantly reduces IAV infection in both cell cultures and mice. Further analysis suggests that the δ isoform of paxillin, rather than the canonical β isoform, plays the key role. Additionally, our data indicate that lysine 68 of paxillin δ undergoes K6-linked ubiquitination and regulates influenza virus replication via modulating endosome-dependent viral entry. These observations contribute to understanding how influenza viruses interact with host factors and may inform therapeutic development.
Source: Cell Reports
Authors: Jiamei Guo, Zhuo Zhou, Ruining Li, Zhifang Xing, Lei Zhang, Shiyi Zhao, Wensheng Wei, Jianwei Wang, Tao Deng
Institutions: Chinese Academy of Sciences, Institute of Microbiology, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou Institute of Systems Medicine, Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research, University of Chinese Academy of Sciences
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,620
Funders: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Chinese Academy of Medical Sciences, Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Key Research and Development Program of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine
OpenAlex ID: W4410734001
